# reload+after+2024-01-23 20:46:56.396155
address1§777 Old Saw Mill River Road
city§Tarrytown
state§NY
zip§10591-6707
country§United States
phone§914 847 7000
website§https://www.regeneron.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
fullTimeEmployees§12463
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Leonard S. Schleifer M.D., Ph.D.', 'age': 70, 'title': 'Co-Founder, President, CEO & Co-Chairman', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 7004069, 'exercisedValue': 0, 'unexercisedValue': 256815824}, {'maxAge': 1, 'name': 'Dr. George D. Yancopoulos M.D., Ph.D.', 'age': 63, 'title': 'Co-Founder, President, Chief Scientific Officer & Co-Chairman', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 6593696, 'exercisedValue': 0, 'unexercisedValue': 242710064}, {'maxAge': 1, 'name': 'Mr. Robert E. Landry Jr.', 'age': 59, 'title': 'Executive VP of Finance & CFO', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1839460, 'exercisedValue': 11097488, 'unexercisedValue': 25114408}, {'maxAge': 1, 'name': 'Dr. Andrew J. Murphy Ph.D.', 'age': 64, 'title': 'Executive Vice President of Research', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 1622950, 'exercisedValue': 19388300, 'unexercisedValue': 83458888}, {'maxAge': 1, 'name': 'Mr. Daniel P. Van Plew', 'age': 50, 'title': 'Executive VP and GM of Industrial Operations & Product Supply', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 1954399, 'exercisedValue': 45282380, 'unexercisedValue': 24788798}, {'maxAge': 1, 'name': 'Ms. Marion E. McCourt', 'age': 63, 'title': 'Executive Vice President of Commercial', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 1500262, 'exercisedValue': 4246309, 'unexercisedValue': 8790830}, {'maxAge': 1, 'name': 'Ms. Patrice  Gilooly', 'title': 'Senior Vice President of Quality Assurance & Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christopher R. Fenimore CPA', 'age': 52, 'title': 'Senior VP, Head of Accounting & Controller', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gerald  Underwood', 'title': 'Senior Vice President of Technical Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bob  McCowan', 'title': 'Senior VP of IT & Chief Information Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§10
compensationRisk§9
shareHolderRightsRisk§10
overallRisk§10
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.155
priceToSalesTrailing12Months§7.596003
currency§USD
dateShortInterest§1702598400
forwardEps§44.41
pegRatio§9.67
exchange§NMS
quoteType§EQUITY
shortName§Regeneron Pharmaceuticals, Inc.
longName§Regeneron Pharmaceuticals, Inc.
firstTradeDateEpochUtc§670602600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§e55aa808-7510-354a-9528-01782e66194d
gmtOffSetMilliseconds§-18000000
targetHighPrice§1125.0
targetLowPrice§700.0
targetMeanPrice§942.05
targetMedianPrice§938.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§22
quickRatio§4.307
earningsGrowth§-0.238
grossMargins§0.53087
ebitdaMargins§0.36765
trailingPegRatio§1.9113
